Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RVC studies offer insights on canine mitral valve repair
Surgical repair is complicated and requires a cardiopulmonary bypass.
Two complementary studies explore surgical risks and recovery outcomes.

Researchers from the Royal Veterinary College (RVC) have uncovered new insights to further understanding of mitral valve repair in dogs.

Across two studies, the new clinical research is expected to lead to better management of surgical risks, as well as helping veterinary teams set owners’ expectations.

Myxomatous (degenerative) mitral valve disease is the most common heart disease in dogs. The condition can cause the mitral valve to deteriorate, leading to valve incompetence and resulting in heart enlargement and, eventually, heart failure.

While surgical repair is often used to treat advanced cases, it is complicated and requires a cardiopulmonary bypass.

With limited research into this procedure, the clinical team at the RVC, which developed open heart surgery in the UK, set out to address this gap with data analysis. In both studies, researchers examined anonymised clinical data from dogs from the UK, Europe and the USA which were undergoing mitral valve repair at the Queen Mother Hospital for Animals at the RVC.

In one study, researchers examined the anaesthetic management and outcomes of 176 dogs undergoing the procedure. They primarily focused on any complications during and around the time of anaesthesia.

For the second study, records from 66 dogs were examined to identify any features from heart scans that could predict whether the heart would stay enlarged during the surgery.

While mitral valve repair was found to be effective, findings highlighted significant intraoperative and postoperative risks that would require management. The research also showed that the most beneficial changes to heart size, known as reverse remodelling, occurred within the first three months of the procedure.

Among researchers’ other findings included the increased risk associated with a longer cardiopulmonary bypass duration. This suggests that time spent on bypass should be minimised if possible.

The study has further highlighted the importance of close perioperative monitoring and rapid-response protocols. Researchers say such protocols are essential for managing anticipated complications.

Statistics revealed that dogs with pre-surgical heart enlargement and a higher body weight were more likely to have persistent left heart enlargement after surgery.

In regards to owner expectations, it was concluded that recovery outcomes from the procedure varied. Researchers say that, when advising owners, veterinary professionals should consider individual patient factors.

Prof Dan Brockman, Professor in Small Animal Surgery and Director of the Cardiothoracic Surgery Service at the RVC, said: “Establishing and maintaining open heart surgical capability at the RVC has been both the most challenging and the most rewarding activity of my 36 years as a specialist small animal surgeon.

“Our team are rightly proud of what we have achieved, but we all know that the route to even greater consistency of results lies in the constant process of reflection, refinement and improvement in every aspect of what we do.”

The study into anaesthetic management and peri-anaesthetic morbidity and mortality can be found here. The study into echocardiographic predictors of persistent left heart enlargement can be found here.

Image © Anna Averianova/Shutterstock

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.